HPI deploys highly specialized teams to help address current pharmaceutical reimbursement challenges including:
- HTA dossier preparation
- Cost effectiveness analysis (CEA) models and technical reports
- Budget impact analysis (BIA) models and technical reports
- Epidemiological studies
- Cost of illness studies
- Systematic Literature Reviews (SLRs) for comparative analysis